Vector-borne diseases
Clinical trials for Vector-borne diseases explained in plain language.
Never miss a new study
Get alerted when new Vector-borne diseases trials appear
Sign up with your email to follow new studies for Vector-borne diseases, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental malaria vaccine aims to block parasite growth
Vaccine CompletedThis trial tests an experimental malaria vaccine called RH5.2-VLP, given with an adjuvant (Matrix-M) to boost the immune response. Healthy adults aged 18–45 receive three doses, and some volunteers are later exposed to malaria parasites in a controlled setting to see if the vacci…
Matched conditions: VECTOR-BORNE DISEASES
Phase 1/2 • Sponsor: University of Oxford • Aim: Vaccine
Last updated Jul 22, 2026 00:00 UTC
-
New malaria drug put to the test in human trial
Knowledge-focused CompletedThis study tested a new experimental drug called MMV367 in 12 healthy adults. Participants were intentionally infected with a controlled, low-level malaria infection to see how well the drug works and how safe it is. The goal was to measure how the body processes the drug and how…
Matched conditions: VECTOR-BORNE DISEASES
Phase 1 • Sponsor: Medicines for Malaria Venture • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC